Samsun University
Samsun, Turkey (Türkiye)
NCT Number: NCT05505890
Regional anesthesia and analgesia technics are widely and securely used during orthopedic surgery. Interfascial plane blocks are the latest used ones for analgesia. There are studies in literature indicating that bupivacaine cause myotoxicity. We aimed to examine plasma CPK(creatine phosphokinase) levels to see whether myotoxicity occurs or not after suprainguinal fascial plane block is applied to patients undergoing knee artroplasty surgery.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Observational
Samsun, Turkey (Türkiye)
During 2 months period all elligible patients undergoing knee artoplasty surgery will be included in the study. Different postoperative analgesic modalities will be used according to the anesthesists experience. During routine blood sample tests plasma CPK levels will be tested 3 times of all patients.(preoperative, postoperative 6th hour, postoperative 24th hour) this data will be recorded for 2 months. After this period of time data will be analysed and patients will be grouped according to the analgesic modalities used.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Suprainguinal fascia iliaca block will be performed after the end of surgery for postoperative analgesia.
Time frame: at postoperative 24th hour
Change from Baseline serum creatine phosphokinase at 24 hours
Time frame: up to 24 hours
Intravenous administration of meperidine 25 mg as a rescue analgesic is planned for patients who complain of severe pain despite multimodal analgesia.
Samsun University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06508177
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions
Samsun, Turkey (Türkiye)
View Trial DetailsNCT04821245
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions
Seattle, Washington, United States
View Trial DetailsNCT00199745
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions
Oslo, Norway
View Trial DetailsNCT07633587
Cardiomyopathies, Cardiovascular Diseases
Paris, France
View Trial Details